End-of-day quote
Taiwan S.E.
06:00:00 2024-05-14 pm EDT
|
5-day change
|
1st Jan Change
|
33.85
TWD
|
-0.15%
|
|
-0.59%
|
-18.43%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,410
|
5,245
|
4,940
|
4,826
|
4,448
|
3,550
|
Enterprise Value (EV)
1 |
4,848
|
5,087
|
5,410
|
5,585
|
5,186
|
4,267
|
P/E ratio
|
9.98
x
|
29
x
|
81
x
|
45.3
x
|
73.7
x
|
-41.3
x
|
Yield
|
6.45%
|
1.76%
|
0.46%
|
0.67%
|
0.96%
|
-
|
Capitalization / Revenue
|
1.19
x
|
1.5
x
|
1.88
x
|
1.58
x
|
1.59
x
|
1.59
x
|
EV / Revenue
|
1.07
x
|
1.45
x
|
2.05
x
|
1.82
x
|
1.85
x
|
1.92
x
|
EV / EBITDA
|
6.09
x
|
17
x
|
37.6
x
|
28.4
x
|
66.9
x
|
552
x
|
EV / FCF
|
-38.6
x
|
1,842
x
|
-13.5
x
|
-22.3
x
|
118
x
|
27.4
x
|
FCF Yield
|
-2.59%
|
0.05%
|
-7.39%
|
-4.48%
|
0.85%
|
3.65%
|
Price to Book
|
2.11
x
|
2.23
x
|
2.23
x
|
2.11
x
|
1.9
x
|
1.64
x
|
Nbr of stocks (in thousands)
|
87,094
|
87,094
|
85,542
|
85,542
|
85,542
|
85,542
|
Reference price
2 |
62.12
|
60.22
|
57.75
|
56.42
|
52.00
|
41.50
|
Announcement Date
|
3/28/19
|
3/30/20
|
3/29/21
|
3/28/22
|
3/27/23
|
3/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,530
|
3,497
|
2,633
|
3,063
|
2,806
|
2,227
|
EBITDA
1 |
796.3
|
300
|
143.9
|
196.6
|
77.53
|
7.731
|
EBIT
1 |
745.5
|
243.4
|
89.68
|
147.3
|
30.3
|
-114
|
Operating Margin
|
16.46%
|
6.96%
|
3.41%
|
4.81%
|
1.08%
|
-5.12%
|
Earnings before Tax (EBT)
1 |
797.4
|
257.1
|
110
|
149.4
|
84.01
|
-89
|
Net income
1 |
562.2
|
194.5
|
62.08
|
106.9
|
60.36
|
-85.91
|
Net margin
|
12.41%
|
5.56%
|
2.36%
|
3.49%
|
2.15%
|
-3.86%
|
EPS
2 |
6.226
|
2.077
|
0.7127
|
1.245
|
0.7056
|
-1.004
|
Free Cash Flow
1 |
-125.7
|
2.762
|
-399.8
|
-250.4
|
43.85
|
155.6
|
FCF margin
|
-2.77%
|
0.08%
|
-15.18%
|
-8.18%
|
1.56%
|
6.99%
|
FCF Conversion (EBITDA)
|
-
|
0.92%
|
-
|
-
|
56.56%
|
2,012.62%
|
FCF Conversion (Net income)
|
-
|
1.42%
|
-
|
-
|
72.65%
|
-
|
Dividend per Share
2 |
4.008
|
1.058
|
0.2645
|
0.3774
|
0.5000
|
-
|
Announcement Date
|
3/28/19
|
3/30/20
|
3/29/21
|
3/28/22
|
3/27/23
|
3/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
470
|
759
|
738
|
717
|
Net Cash position
1 |
562
|
158
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
3.266
x
|
3.86
x
|
9.514
x
|
92.8
x
|
Free Cash Flow
1 |
-126
|
2.76
|
-400
|
-250
|
43.9
|
156
|
ROE (net income / shareholders' equity)
|
25.7%
|
7.99%
|
2.74%
|
4.73%
|
2.6%
|
-3.77%
|
ROA (Net income/ Total Assets)
|
12.8%
|
3.64%
|
1.31%
|
1.97%
|
0.39%
|
-1.53%
|
Assets
1 |
4,389
|
5,337
|
4,739
|
5,416
|
15,307
|
5,629
|
Book Value Per Share
2 |
29.50
|
27.00
|
25.90
|
26.70
|
27.40
|
25.30
|
Cash Flow per Share
2 |
12.80
|
14.50
|
15.40
|
13.10
|
14.10
|
14.00
|
Capex
1 |
458
|
459
|
548
|
289
|
140
|
56.1
|
Capex / Sales
|
10.12%
|
13.13%
|
20.81%
|
9.44%
|
4.98%
|
2.52%
|
Announcement Date
|
3/28/19
|
3/30/20
|
3/29/21
|
3/28/22
|
3/27/23
|
3/15/24
|
|
1st Jan change
|
Capi.
|
---|
| -18.43% | 90.1M | | +17.44% | 66.52B | | +3.11% | 50.34B | | +17.62% | 42.01B | | +20.88% | 26.68B | | +12.26% | 19.97B | | +2.07% | 17.32B | | -23.54% | 15.7B | | +0.96% | 15.53B | | -11.70% | 14.99B |
Other Specialty Chemicals
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly** -40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff** BENEFIT NOW**0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
|